The research within the PCDIAB consortium focuses on the development of a portable bihormonal (insulin and glucagon) artificial pancreas.
To this end the PCDIAB consortium will:

  • Include automated closed loop glycaemic control
  • Incorporate exercise detection in the control algorithm
  • Develop a glucagon formulation
  • Perform a multinational controlled trial to compare the bihormonal artificial pancreas to with standard insulin therapy in daily life